The Development of Patient-Specific Cardiomyocytes Differentiated from Induced Pluripotent Stem Cells as a model for the Molecular, Cellular, and Electrophysiological Characterization of Inherited Cardiac Arrhythmias

The Development of Patient-Specific Cardiomyocytes Differentiated from Induced Pluripotent Stem Cells as a model for the Molecular, Cellular, and Electrophysiological Characterization of Inherited Cardiac Arrhythmias - iPS Cell model for Inherited Cardiac Arrhythmias

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32488

Enrollment

600

Registered

2010-03-03

Start date

2009-12-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart rhythm disorders inherited arrhythmias

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult patients diagnosed with inherited arrhythmias.

Exclusion criteria

Exclusion criteria: The inclusion criteria includes only the study population. Since there is minimal burden on patients, there is no reason why someone in this group can not participate in this study.

Design outcomes

Primary

Measure	Time frame
: Cellular, molecular and electrophysiological characterization of the iPS-CM.	—

Secondary

Measure	Time frame
n.v.t.	—

Countries

Netherlands

Outcome results